Effect of Face Masks on Pulmonary Function in Patients With COPD

NCT05742880 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-03-19

No results posted yet for this study

Summary

Given the heightened vulnerability of COPD patients to severe illness upon SARS-CoV-2 infection, precautions like mask-wearing are deemed crucial. Yet, mask-wearing can exacerbate breathlessness and discomfort in this demographic. This study aims to assess the effects of wearing a face mask during 6-Minute-Walking-Tests (6-MWT) among COPD patients.

Conditions

  • COPD
  • Walking, Difficulty

Interventions

DIAGNOSTIC_TEST

6 Minute Walking Test

6 Minute walking test

DIAGNOSTIC_TEST

Blood gas analysis

Blood gas analyisis

PROCEDURE

Wearing a Surgical Facemask

Wearing a Surgical Facemask

PROCEDURE

Wearing a FFP2- Facemask

Wearing a FFP2- Facemask

PROCEDURE

Wearing no Mask

Wearing no Mask

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Marco Idzko, Prof. · Medical University of Vienna

  • Lukasz Antoniewicz, MD, PhD · Medical University of Vienna

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05742880 on ClinicalTrials.gov